rs150797476

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_014391.3(ANKRD1):​c.197G>A​(p.Arg66Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000674 in 1,613,780 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R66G) has been classified as Benign.

Frequency

Genomes: 𝑓 0.00087 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00065 ( 0 hom. )

Consequence

ANKRD1
NM_014391.3 missense

Scores

2
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:11O:1

Conservation

PhyloP100: 0.590
Variant links:
Genes affected
ANKRD1 (HGNC:15819): (ankyrin repeat domain 1) The protein encoded by this gene is localized to the nucleus of endothelial cells and is induced by IL-1 and TNF-alpha stimulation. Studies in rat cardiomyocytes suggest that this gene functions as a transcription factor. Interactions between this protein and the sarcomeric proteins myopalladin and titin suggest that it may also be involved in the myofibrillar stretch-sensor system. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.007817984).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ANKRD1NM_014391.3 linkuse as main transcriptc.197G>A p.Arg66Gln missense_variant 2/9 ENST00000371697.4 NP_055206.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ANKRD1ENST00000371697.4 linkuse as main transcriptc.197G>A p.Arg66Gln missense_variant 2/91 NM_014391.3 ENSP00000360762 P1

Frequencies

GnomAD3 genomes
AF:
0.000874
AC:
133
AN:
152158
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00202
Gnomad EAS
AF:
0.00174
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000848
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00141
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.000935
AC:
235
AN:
251288
Hom.:
0
AF XY:
0.000825
AC XY:
112
AN XY:
135830
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000578
Gnomad ASJ exome
AF:
0.00328
Gnomad EAS exome
AF:
0.00239
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00143
Gnomad NFE exome
AF:
0.00106
Gnomad OTH exome
AF:
0.000652
GnomAD4 exome
AF:
0.000653
AC:
955
AN:
1461504
Hom.:
0
Cov.:
32
AF XY:
0.000686
AC XY:
499
AN XY:
727062
show subpopulations
Gnomad4 AFR exome
AF:
0.000179
Gnomad4 AMR exome
AF:
0.000112
Gnomad4 ASJ exome
AF:
0.00275
Gnomad4 EAS exome
AF:
0.000856
Gnomad4 SAS exome
AF:
0.0000464
Gnomad4 FIN exome
AF:
0.00150
Gnomad4 NFE exome
AF:
0.000637
Gnomad4 OTH exome
AF:
0.000762
GnomAD4 genome
AF:
0.000873
AC:
133
AN:
152276
Hom.:
0
Cov.:
32
AF XY:
0.000766
AC XY:
57
AN XY:
74460
show subpopulations
Gnomad4 AFR
AF:
0.000168
Gnomad4 AMR
AF:
0.000262
Gnomad4 ASJ
AF:
0.00202
Gnomad4 EAS
AF:
0.00174
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000848
Gnomad4 NFE
AF:
0.00141
Gnomad4 OTH
AF:
0.000473
Alfa
AF:
0.00121
Hom.:
0
Bravo
AF:
0.000555
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00105
AC:
9
ExAC
AF:
0.000955
AC:
116
EpiCase
AF:
0.00115
EpiControl
AF:
0.000652

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:11Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:5Other:1
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenFeb 01, 2023ANKRD1: BP4, BS1 -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely benign, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpJul 31, 2017Variant summary: The ANKRD1 c.197G>A (p.Arg66Gln) variant involves the alteration of a non-conserved nucleotide, resulting in a missense change in the ankyrin repeat-containing domain (InterPro). 4/5 in silico tools predict benign outcome for this variant. This variant was found in 116/122204 control chromosomes (ExAC) at a frequency of 0.0009492, which is approximately 28 times the estimated maximal expected allele frequency of a pathogenic ANKRD1 variant (0.0000344), suggesting this variant is likely a benign polymorphism. In gnomAD, the variants allele frequency is 0.001079 (299/ 277022 chromosomes). This variant has been reported in one case who had family history of premature sudden deaths in first-degree relatives (Duboscq-Bidot_EJH_2009). Functional analysis in the same study showed a non-significant, mild effect on transcriptional repression was observed as well as a non-significant increase in cell area in cardiomyocytes, suggesting protein function is not significantly impacted by the variant. In ClinVar, while four clinical labs have classified it as uncertain significance, three have classified it as likely benign. Taken together, based on its allele frequency in general population and the possibility that it is likely to be a functional polymorphism rather than causal variant, this variant is classified as likely benign. -
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Uncertain significance, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Jul 14, 2015- -
Likely benign, criteria provided, single submitterclinical testingGeneDxMar 25, 2021This variant is associated with the following publications: (PMID: 22337857, 19525294, 23861362, 24503780, 23299917) -
not provided, no classification providedphenotyping onlyGenomeConnect, ClinGen-Variant interpretted as Uncertain significance and reported on 01-06-2017 by Lab or GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. -
not specified Uncertain:1Benign:2
Uncertain significance, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMay 19, 2015proposed classification - variant undergoing re-assessment, contact laboratory -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Primary dilated cardiomyopathy Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -
Likely benign, criteria provided, single submitterresearchBiesecker Lab/Clinical Genomics Section, National Institutes of HealthJun 24, 2013- -
Cardiomyopathy Benign:1
Benign, criteria provided, single submitterclinical testingCHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern OntarioApr 25, 2018- -
ANKRD1-related dilated cardiomyopathy Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsFeb 22, 2018This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.14
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.092
T
Eigen
Benign
-0.19
Eigen_PC
Benign
0.044
FATHMM_MKL
Benign
0.73
D
LIST_S2
Benign
0.81
T
M_CAP
Benign
0.012
T
MetaRNN
Benign
0.0078
T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
1.3
L
MutationTaster
Benign
0.68
N
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-0.46
N
REVEL
Uncertain
0.29
Sift
Benign
0.18
T
Sift4G
Benign
0.58
T
Polyphen
0.0
B
Vest4
0.22
MVP
0.77
MPC
0.19
ClinPred
0.053
T
GERP RS
5.8
Varity_R
0.14
gMVP
0.22

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs150797476; hg19: chr10-92679936; API